FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

O Van Cutsem

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Phenomena

Karnofsky Performance Status

Co-author Network

Publications

TOP 3
Marianne Paesmans; Arnaud Scherpereel; O Van Cutsem; Paul Van Houtte; Thierry Berghmans; Anna P Efremidis; V Giner; Jean-Jacques Lafitte; N Leclercq; J Lecomte; Anne-Pascale Meert; Jean-Paul Sculier
Validation and comparison of several published prognostic systems for patients with small cell lung cancer.
Jean-Paul Sculier; Jean-Jacques Lafitte; Marianne Paesmans; J Lecomte; CG Alexopoulos; O Van Cutsem; V Giner; Anna P Efremidis; MC Berchier; T Collon; Anne-Pascale Meert; Arnaud Scherpereel; Vincent Ninane; George Koumakis; M M Vaslamatzis; N Leclercq; Thierry Berghmans
Chemotherapy improves low performance status lung cancer patients.
Thierry Berghmans; Jean-Jacques Lafitte; J Lecomte; CG Alexopoulos; O Van Cutsem; V Giner; Anna P Efremidis; MC Berchier; T Collon; Anne-Pascale Meert; Arnaud Scherpereel; Vincent Ninane; N Leclercq; Marianne Paesmans; Jean-Paul Sculier
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of O Van Cutsem (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Marianne Paesmans; Arnaud Scherpereel; O Van Cutsem; Paul Van Houtte; Thierry Berghmans; Anna P Efremidis; V Giner; Jean-Jacques Lafitte; N Leclercq; J Lecomte; Anne-Pascale Meert; Jean-Paul Sculier
Validation and comparison of several published prognostic systems for patients with small cell lung cancer.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2011;38(3):657-63.
2007: Jean-Paul Sculier; Jean-Jacques Lafitte; Marianne Paesmans; J Lecomte; CG Alexopoulos; O Van Cutsem; V Giner; Anna P Efremidis; MC Berchier; T Collon; Anne-Pascale Meert; Arnaud Scherpereel; Vincent Ninane; George Koumakis; M M Vaslamatzis; N Leclercq; Thierry Berghmans
Chemotherapy improves low performance status lung cancer patients.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2007;30(6):1186-92.
2007: Thierry Berghmans; Jean-Jacques Lafitte; J Lecomte; CG Alexopoulos; O Van Cutsem; V Giner; Anna P Efremidis; MC Berchier; T Collon; Anne-Pascale Meert; Arnaud Scherpereel; Vincent Ninane; N Leclercq; Marianne Paesmans; Jean-Paul Sculier
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.
British journal of cancer 2007;96(11):1644-9.
2007: Jean-Paul Sculier; Jean-Jacques Lafitte; J Lecomte; CG Alexopoulos; O Van Cutsem; V Giner; Anna P Efremidis; MC Berchier; T Collon; Anne-Pascale Meert; Arnaud Scherpereel; Vincent Ninane; Marianne Paesmans; Thierry Berghmans
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(6):1037-42.
2002: Jean-Paul Sculier; Jean-Jacques Lafitte; J Lecomte; Thierry Berghmans; J Thiriaux; O Van Cutsem; Anna P Efremidis; Vincent Ninane; Marianne Paesmans; P Mommen; Jean Klastersky
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1454-9.
2002: Jean-Paul Sculier; Thierry Berghmans; Jean-Jacques Lafitte; M Richez; P Recloux; O Van Cutsem; Vincent Ninane; P Mommen; Marianne Paesmans; Jean Klastersky
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2002;37(1):73-7.
2001: Jean-Paul Sculier; Marianne Paesmans; J Lecomte; O Van Cutsem; Jean-Jacques Lafitte; Thierry Berghmans; George Koumakis; MC Florin; J Thiriaux; J Michel; V Giner; MC Berchier; P Mommen; Vincent Ninane; Jean Klastersky
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
British journal of cancer 2001;85(10):1444-51.
2000: Marianne Paesmans; Jean-Paul Sculier; J Lecomte; J Thiriaux; P Libert; R Sergysels; G Bureau; G Dabouis; O Van Cutsem; P Mommen; Vincent Ninane; Jean Klastersky
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
Cancer 2000;89(3):523-33.
1999: Jean-Paul Sculier; Marianne Paesmans; Jean-Jacques Lafitte; J Baumöhl; J Thiriaux; O Van Cutsem; P Recloux; G Bureau; MC Berchier; Constantinos Zacharias; P Mommen; T Bosschaerts; Thierry Berghmans; P van Houtte; Vincent Ninane; Jean Klastersky
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):295-303.
1998: Jean-Paul Sculier; Marianne Paesmans; Vincent Ninane; V Giner; G Bureau; Jean-Jacques Lafitte; J Baumöhl; J Thiriaux; O Van Cutsem; P Recloux; MC Berchier; Constantinos Zacharias; P Mommen; P van Houtte; Jean Klastersky
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Lung cancer (Amsterdam, Netherlands) 1998;22(3):201-13.
1997: Marianne Paesmans; Jean-Paul Sculier; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; R Sergysels; P Mommen; Jean Klastersky
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
European journal of cancer (Oxford, England : 1990) 1997;33(14):2326-32.
1997: Jean-Paul Sculier; Marianne Paesmans; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; J Schmerber; V Giner; MC Berchier; P Mommen; R Sergysels; Jean Klastersky
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party].
Revue des maladies respiratoires 1997;14(6):445-9.
1996: M Borges; Jean-Paul Sculier; Marianne Paesmans; M Richez; G Bureau; G Dabouis; J Lecomte; J Michel; O Van Cutsem; J Schmerber; V Giner; MC Berchier; R Sergysels; P Mommen; Jean Klastersky
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).
Lung cancer (Amsterdam, Netherlands) 1996;16(1):21-33.
1996: Jean-Paul Sculier; Marianne Paesmans; G Bureau; V Giner; J Lecomte; J Michel; MC Berchier; O Van Cutsem; U Küstner; F Kroll; R Sergysels; P Mommen; Jean Klastersky
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(8):2337-44.
1995: Marianne Paesmans; Jean-Paul Sculier; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; R Sergysels; P Mommen
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1221-30.
1995: Jean-Paul Sculier; G Bureau; V Giner; J Thiriaux; J Michel; MC Berchier; O Van Cutsem; U Küstner; F Kroll; P Mommen
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
Seminars in oncology 1995;22(1 Suppl 2):18-22.
1994: Jean Klastersky; Jean-Paul Sculier; F Ries; G Dabouis; P Libert; J Schmerber; J Thiriaux; MC Berchier; G Bureau; O Van Cutsem
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1994;11(5-6):373-84.
1994: Jean Klastersky; Jean-Paul Sculier; F Ries; G Dabouis; P Libert; J Schmerber; J Thiriaux; MC Berchier; G Bureau; O Van Cutsem
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(7):641-3.
1994: Jean-Paul Sculier; Marianne Paesmans; G Bureau; G Dabouis; P Libert; G Vandermoten; O Van Cutsem; MC Berchier; F Ries; J Michel
[Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
Revue des maladies respiratoires 1994;11(3):257-61.
1994: Jean-Paul Sculier; Marianne Paesmans; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; J Schmerber; V Giner
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party.
European journal of cancer (Oxford, England : 1990) 1994;30A(9):1342-7.
1993: Jean-Paul Sculier; Marianne Paesmans; G Bureau; G Dabouis; P Libert; G Vandermoten; O Van Cutsem; MC Berchier; F Ries; J Michel
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1858-65.